ALGN stock forecast, quote, news & analysis
Align Technology is the leading manufacturer of clear aligners... Show more
Align Technology (ALGN) Stock Analysis: Innovation Recognition Fuels Rebound
Key Takeaways
- ALGN stock has rebounded notably in recent weeks, reflecting positive investor sentiment ahead of quarterly earnings.
- Analysts maintain a consensus "Buy" rating with an average price target around $207, implying upside potential.
- Recent recognition as a LexisNexis Top 100 Global Innovator for the fifth year highlights ongoing R&D leadership.
- Q4 2025 delivered record revenue of $1.05 billion, beating expectations and supporting 2026 growth guidance of 3-4%.
- Key growth drivers include direct ship orthodontics (DSO) momentum and expansion in teen and kids segments.
Current Market Snapshot
Align Technology (ALGN) stock has demonstrated resilience in recent trading sessions, rebounding from earlier lows within its 52-week range of approximately $122 to $208. The shares have gained traction amid broader market stability and anticipation surrounding upcoming quarterly results, with year-to-date performance outpacing many healthcare peers. Trading volume remains consistent, and volatility has been moderate compared to the S&P 500, underscoring investor confidence in the company's clear aligner leadership. Analyst upgrades and positive coverage have contributed to this upward momentum, positioning ALGN for potential continued strength in the orthodontic market cycle.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top-performing AI trading bots from its library of over 350 bots that trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies, timeframes, and styles—such as short-term scalping (5-minute intervals) or longer swings (up to 55 days)—tailored to current market conditions like volatility in semiconductors or communications tech. Only the most suitable, high-performing ones earn a spot in this dynamic trending section. Performance stats vary widely: annualized returns range from 15% to 168%, win rates 48% to 88%, profit factors 1.5 to 6.9, and profit-to-drawdown ratios up to 21.5. Examples include a semiconductors bot with 104% annualized return and 64% win rate on tickers like LRCX and ASML. Explore these bots for real-time signals and copy-trading options to enhance your strategy.
Recent Developments Driving ALGN Price Action
In the past 30 days, Align Technology (ALGN) stock has experienced a rebound, climbing around 14% in the latest month, driven by earnings anticipation and positive recognition. Investors are closely watching the upcoming Q1 2026 earnings release on April 29, with consensus estimates calling for $1.02 billion in revenue and $2.26 EPS—a double-digit earnings increase expected year-over-year. Articles previewing the report highlight the company's history of earnings beats and factors like clear aligner volume growth.
On April 15, Align earned the "Five-Year Top 100 Global Innovator" distinction from LexisNexis, marking its fifth consecutive year on the list. This accolade, based on patent filings and R&D intensity, reinforced perceptions of the company's leadership in digital orthodontics, including Invisalign systems and iTero scanners, boosting sentiment and contributing to the share price uptick.
Analyst actions further supported the rally. Morgan Stanley maintained an Equal-Weight rating but raised its price target from $169 to $188 on April 24, citing steady fundamentals. Broader consensus remains "Buy," with targets averaging $206.86 (range $175-$240), implying 8-10% upside from recent levels around $190. Coverage from Morningstar and Argus also leaned positive, emphasizing rebound potential post-pullback.
Earlier Q4 2025 results, reported in February, set a strong tone with record $1.05 billion revenue (up 5.3% YoY) and EPS of $3.29, beating forecasts and lifting shares 9% post-release. While not within the exact 30-day window, this momentum carried into recent weeks. No major macroeconomic pressures or regulatory hurdles emerged; instead, focus on DSO expansion and teen/kids aligner adoption sustained buying interest. Overall, these developments linked directly to the stock's recent price strength, with lower volatility signaling reduced risk perception.
2026 Outlook and Key Factors to Monitor
Align Technology enters 2026 with management guiding 3-4% full-year revenue growth and mid-single-digit increases in clear aligner volumes, building on Q4 momentum. Investors should track direct ship orthodontics (DSO) penetration, which accelerates case starts via digital workflows, alongside international expansion and uptake in teen and kids segments through initiatives like Invisalign for Kids.
Digital innovation remains central, with iTero scanner integrations and AI-enhanced treatment planning poised to drive efficiency. The $1 billion stock repurchase program signals confidence in capital allocation. Opportunities lie in orthodontic market share gains versus traditional braces, supported by category leadership.
Risks include consumer spending sensitivity in elective procedures amid economic uncertainty, potential margin pressures from investments, and competition from generics or rivals. Regulatory scrutiny on dental devices and supply chain dynamics warrant attention. Balanced monitoring of quarterly guidance execution will shape the trajectory through the year.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ALGN in upward trend: price rose above 50-day moving average on June 11, 2026
ALGN moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALGN's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on May 27, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where ALGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALGN as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 10-day moving average for ALGN crossed bearishly below the 50-day moving average on May 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ALGN broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALGN entered a downward trend on June 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.018) is normal, around the industry mean (4.438). P/E Ratio (29.385) is within average values for comparable stocks, (185.236). Projected Growth (PEG Ratio) (0.922) is also within normal values, averaging (3.445). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (3.077) is also within normal values, averaging (65.784).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of the invisalign system for treating malocclusion
Industry PharmaceuticalsOther